Company intelligence / Profile preview

Hero Scientific

Ownership: Private
Development stage: Preclinical

Overview

Hero Scientific is developing a rapid, non-invasive, at-home diagnostic test for Strep A ("strep throat") using a gargle-and-spit method. Their lead product, EZSTREP™, is currently pending FDA approval. The company also has R&D activities in next-generation devices, STD testing, and automated sample processing. No published clinical results yet; the focus is on enabling accurate home-based infectious disease diagnostics to reduce unnecessary antibiotic use.

Therapeutic areas: Infectious Diseases
Modalities: Device
Industry: Protein Biomarker Diagnostics

Drug pipeline

1 asset

EZ STREP

Pre-clinical

Indications: Strep A

Beyond the preview

Go deeper on Hero Scientific.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hero Scientific.

Explore the full profile